Tags

Type your tag names separated by a space and hit enter

Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients.
Nephrol Dial Transplant. 1997 Jan; 12(1):167-73.ND

Abstract

BACKGROUND

Fibrinogen and factor VII coagulant activity (VIIc), risk factors for cardiovascular disease (CVD) in the general population, could contribute to CVD risk in renal transplant recipients (RTR).

METHODS

We measured fibrinogen and VIIc in 38 RTR and 31 controls, along with prothrombin fragment F1 + 2 and D-Dimer (markers of coagulation and fibrinolytic activation), plasma lipids and the acute phase response cytokine, interleukin 6. The effect of genetic polymorphisms of beta-fibrinogen (G/A-455) and factor VII (Arg/Gln353) was explored.

RESULTS

F1 + 2, D-Dimer, and fibrinogen were increased in all RTR, indicating a chronic prothrombotic state. Fibrinogen correlated with age. F1 + 2, and trough cyclosporin A (CsA). RTR carriers of the A-455 allele had a greater increment in plasma fibrinogen concentration and correlation with CsA than homozygotes for the G-455 allele. Interleukin 6 was increased in RTR confirming that a persistent lowgrade acute-phase response could contribute to increased fibrinogen. Differences in plasma VIIc were associated with factor VII genotype, disease status, and blood lipids. Carriers of the Gln353 allele had 30% lower VIIc when compared with Arg353 homozygotes, which could confer a reduced thrombotic risk. The 12 RTR with CVD or metabolic complications (RTR+) were more hyperlipidaemic and had higher fibrinogen and VIIc than the 26 RTR free of disease complications (RTR-), or the controls.

CONCLUSIONS

Long-term RTR manifest features of a chronic prothrombotic and persistent inflammatory state. Alterations in fibrinogen and VIIc in RTR arise in part as a result of interactions between common genetic and environmental factors, and these changes could contribute to the increased risk of CVD in RTR.

Authors+Show Affiliations

Oxford Renal Unit, Churchill Hospital, Oxford, UK.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

9027794

Citation

Irish, A B., and F R. Green. "Environmental and Genetic Determinants of the Hypercoagulable State and Cardiovascular Disease in Renal Transplant Recipients." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 12, no. 1, 1997, pp. 167-73.
Irish AB, Green FR. Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant. 1997;12(1):167-73.
Irish, A. B., & Green, F. R. (1997). Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 12(1), 167-73.
Irish AB, Green FR. Environmental and Genetic Determinants of the Hypercoagulable State and Cardiovascular Disease in Renal Transplant Recipients. Nephrol Dial Transplant. 1997;12(1):167-73. PubMed PMID: 9027794.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients. AU - Irish,A B, AU - Green,F R, PY - 1997/1/1/pubmed PY - 1997/1/1/medline PY - 1997/1/1/entrez SP - 167 EP - 73 JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association JO - Nephrol Dial Transplant VL - 12 IS - 1 N2 - BACKGROUND: Fibrinogen and factor VII coagulant activity (VIIc), risk factors for cardiovascular disease (CVD) in the general population, could contribute to CVD risk in renal transplant recipients (RTR). METHODS: We measured fibrinogen and VIIc in 38 RTR and 31 controls, along with prothrombin fragment F1 + 2 and D-Dimer (markers of coagulation and fibrinolytic activation), plasma lipids and the acute phase response cytokine, interleukin 6. The effect of genetic polymorphisms of beta-fibrinogen (G/A-455) and factor VII (Arg/Gln353) was explored. RESULTS: F1 + 2, D-Dimer, and fibrinogen were increased in all RTR, indicating a chronic prothrombotic state. Fibrinogen correlated with age. F1 + 2, and trough cyclosporin A (CsA). RTR carriers of the A-455 allele had a greater increment in plasma fibrinogen concentration and correlation with CsA than homozygotes for the G-455 allele. Interleukin 6 was increased in RTR confirming that a persistent lowgrade acute-phase response could contribute to increased fibrinogen. Differences in plasma VIIc were associated with factor VII genotype, disease status, and blood lipids. Carriers of the Gln353 allele had 30% lower VIIc when compared with Arg353 homozygotes, which could confer a reduced thrombotic risk. The 12 RTR with CVD or metabolic complications (RTR+) were more hyperlipidaemic and had higher fibrinogen and VIIc than the 26 RTR free of disease complications (RTR-), or the controls. CONCLUSIONS: Long-term RTR manifest features of a chronic prothrombotic and persistent inflammatory state. Alterations in fibrinogen and VIIc in RTR arise in part as a result of interactions between common genetic and environmental factors, and these changes could contribute to the increased risk of CVD in RTR. SN - 0931-0509 UR - https://www.unboundmedicine.com/medline/citation/9027794/Environmental_and_genetic_determinants_of_the_hypercoagulable_state_and_cardiovascular_disease_in_renal_transplant_recipients_ L2 - https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/12.1.167 DB - PRIME DP - Unbound Medicine ER -